Close

Quest Diagnostics, Inc. (DGX) Tops Q4 EPS by 4c; Guides

January 30, 2014 7:47 AM EST Send to a Friend
Quest Diagnostics, Inc. (NYSE: DGX) reported Q4 EPS of $0.97, $0.04 better than the analyst estimate of $0.93. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login